Willis Towers Watson (WTW) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
3 Aug, 2026Executive summary
Q2 2026 revenue rose 9% year-over-year to $2.47 billion, with 5% organic growth.
Adjusted diluted EPS increased 17% to $3.35, while reported diluted EPS fell 27% to $2.43.
Propel AI acceleration plan launched, targeting $400 million in run-rate savings and a 30% adjusted operating margin by 2028, with a $625 million investment.
Returned $450 million to shareholders via share repurchases and paid $90 million in dividends in Q2 2026.
Major acquisitions included Newfront Insurance Holdings and Cushon, expanding technology and benefits offerings.
Financial highlights
Q2 2026 revenue: $2.47B (Q2 2025: $2.26B); six-month revenue: $4.88B (2025: $4.48B).
Adjusted operating margin reached 19.5%, up 100 basis points year-over-year.
Adjusted EBITDA margin for Q2 2026: 21.5% (Q2 2025: 20.8%).
Free cash flow for H1 2026 was $360 million, up from $217 million in the prior year.
Net income declined 30% year-over-year to $229 million, mainly due to higher expenses and tax rates.
Outlook and guidance
Propel AI plan expected to deliver $350 million in net run-rate savings and 30% adjusted operating margin by 2028.
Full-year 2026 guidance remains unchanged, with mid-single-digit organic growth and annual margin expansion.
Share repurchases of $1.0B or greater expected for 2026, subject to market conditions.
Foreign currency expected to provide a $0.35 tailwind to adjusted diluted EPS for 2026.
Newfront acquisition expected to be $0.10 dilutive to adjusted EPS in 2026, with $250 million post-close revenue.
Latest events from Willis Towers Watson
- Q2 saw 6% organic growth, margin expansion, and raised 2024 guidance with strong capital returns.WTW
Q2 20248 Jul 2026 - 5% organic growth and margin gains offset TRANZACT sale, driving higher net income.WTW
Q1 20258 Jul 2026 - 5% organic growth, margin gains, and $473M in savings set up for continued strong performance.WTW
Q4 20248 Jul 2026 - Organic growth and margin expansion offset divestiture impacts, boosting adjusted EPS and cash flow.WTW
Q4 20258 Jul 2026 - Q2 2025 saw 5% organic growth, margin expansion, and net income up 135% year-over-year.WTW
Q2 20258 Jul 2026 - Revenue up 8%, adjusted EPS up 19%, with margin expansion and $300M in buybacks.WTW
Q1 202630 Apr 2026 - Six major proposals, board refreshment, strong performance, and enhanced risk oversight highlighted.WTW
Proxy filing27 Mar 2026 - Key votes include director elections, auditor ratification, and share plan amendments.WTW
Proxy filing27 Mar 2026 - Q3 saw 6% revenue growth, margin gains, and a $1.67B loss from TRANZACT sale charges.WTW
Q3 202417 Jan 2026